Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other neoplasm 1Head & Neck 1

Conditions

Precancerous Conditions 26Neoplasms 8Obesity-Related Malignant Neoplasm 7Myelodysplastic Syndromes 5Leukemia, Myeloid, Acute 5Leukemia 5Uterine Cervical Neoplasms 4Preleukemia 4Neoplasms by Histologic Type 4Hematologic Diseases 4Bone Marrow Diseases 4Primary Myelofibrosis 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Myeloproliferative Disorders 3Lymphoma 3Leukemia, Lymphocytic, Chronic, B-Cell 3Leukemia, Biphenotypic, Acute 3Keratosis, Actinic 3Immunoproliferative Disorders 3Immune System Diseases 3Head and Neck Neoplasms 3Colorectal Neoplasms 3Colonic Neoplasms 3Advanced Malignant Neoplasm 3Uterine Cervical Dysplasia 2Thrombocythemia, Essential 2Stomach Neoplasms 2Skin Diseases 2Neoplasms by Site 2Myelodysplastic-Myeloproliferative Diseases 2

Interventions

Nivolumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Tobacco Smoking × Other neoplasm × 1 year × Clear all
NCT03347838 2025-12-12

Nivolumab for the Reversal of Squamous Dysplasia in High Risk Current and Former Smokers

University of Colorado, Denver

Phase 2 Active not recruiting
19 enrolled 10 charts
Head & NeckOther neoplasm

Tobacco Smoking, Head and Neck Neoplasms, Precancerous Conditions

Data powered by HemOnc (CC BY 4.0) Colophon âš¡